FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS)
$12.88 -0.11 (-0.8468%)
Analysed FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) News Sources
Should Value Investors Buy Fresenius SE & Co. (FSNUY) Stock?
15-06-2026
yahoo.com
Fresenius Medical Care dips after US proposes lower dialysis reimbursement rate
25-06-2026
yahoo.com
IV Equipment Market by Type, Application, End User - Global Forecast to 2031
30-06-2026
yahoo.com
Fresenius establishes venture fund of more than €200 million to drive healthcare innovation
23-07-2026
yahoo.com
Hikma and Fresenius best positioned from Trump's generic drug tariffs, says Citi
23-07-2026
proactiveinvestors.com
Global Apheresis Market to Reach USD 4.41 Billion by 2031, Driven by Plasma-Based Therapies and Automated Technologies
24-07-2026
yahoo.com
Ensign Group (ENSG) Q2 Earnings and Revenues Top Estimates
27-07-2026
yahoo.com
Chemed (CHE) Tops Q2 Earnings and Revenue Estimates
28-07-2026
yahoo.com
Fresenius (XTRA:FRE) Stock May Still Be Cheap On Its 66% Run
30-07-2026
yahoo.com
Fresenius Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate
31-07-2026
yahoo.com
What is the current price of FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS)?
The current price of FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) is $12.88.
FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) since the previous trading day is $-0.11.
FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) since the previous trading day is -0.8468%.
What is the most recent average sentiment score for FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS)?
The most recent average sentiment score for FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) is 71 out of 100.
What is the most recent average sentiment for FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS)?
The most recent sentiment for FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS) is .
SEC-8K** Filing Available For FRESENIUS SE & CO-SPN ADR (FSNUY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.